Sword Diagnostics Inc announces that the United States Patent Office (USPTO) has issued patent number 7,599,057 titled "Method and Apparatus for Detection of Biological Organisms using Raman Scattering" to the company. The patent covers the core technology which focuses on improved sensitivity.
"The issuance of this patent supports the underlying strategy as we move forward with our continued development and commercialization," said Dave Dingott, CEO and President of Sword Diagnostics.
"The feedback from our immunoassay customers validates the high degree of need in the market for a technology that delivers improved sensitivity without compromising in cost or complexity of the test."
Sword Diagnostic’s mission is to improve existing medical diagnostic tests by providing additional sensitivity to each currently available antibody-based test as well as allowing clinicians to monitor new markers that are not detectable with current technology.
Source: Sword Diagnostics
